Curated News
By: NewsRamp Editorial Staff
November 13, 2026
SS Innovations Promotes Srivastava to President, Appoints Gary Lo CFO
TLDR
- SS Innovations promotes Dr. Vishwa Srivastava to president and Gary Lo to CFO to drive U.S. expansion and global market advantage for its surgical robots.
- The leadership changes support SS Innovations' plan to advance the SSi Mantra through FDA 510(k) review and CE marking certification while expanding its technology pipeline.
- SS Innovations aims to make affordable robotic surgery accessible worldwide, improving healthcare outcomes through cost-effective technology and global expansion.
- The SSi Mantra surgical robot features up to five arms, 3D 4K vision, and tele-surgery capability, and has been clinically validated in over 190 procedure types in India.
Impact - Why it Matters
The promotion of Dr. Vishwa Srivastava and appointment of Gary Lo come at a critical time for SS Innovations as it seeks FDA clearance and European CE marking for its SSi Mantra surgical robotic system. These leadership moves signal the company's commitment to expanding into the U.S. and global markets, potentially increasing competition in the surgical robotics industry and advancing access to affordable robotic surgery. For investors, the experienced leadership team may enhance the company's ability to navigate regulatory hurdles and drive growth, impacting SSII's stock performance and the broader adoption of robotic surgical technologies.
Summary
SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, has promoted Dr. Vishwa Srivastava to president and appointed Gary Lo as chief financial officer. Srivastava, who previously served as CEO of the company’s Asia Pacific operations, will focus on building its U.S. business and leading global operations. Both executives are based in the United States. Lo brings more than three decades of financial leadership experience across technology companies, including the medical technology sector, with expertise in capital markets, financial planning and strategic growth.
The leadership changes come as SS Innovations advances its international expansion plans for the SSi Mantra surgical robotic system. The company is responding to questions from the U.S. Food and Drug Administration (“FDA”) regarding its 510(k) premarket notification while pursuing CE marking certification in the European Union. SS Innovations is also finalizing a pipeline of additional health care technologies at its research and development facility in India, with plans to introduce them in the coming months.
SS Innovations develops innovative surgical robotic technologies with a vision to make robotic surgery affordable and accessible to a larger segment of the global population. The company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. For more information, visit ssinnovations.com or LinkedIn.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, SS Innovations Promotes Srivastava to President, Appoints Gary Lo CFO
